The stock of CryoPort Inc (NASDAQ:CYRX) is a huge mover today! About 85,643 shares traded hands or 573.93% up from the average. CryoPort Inc (NASDAQ:CYRX) has risen 2.23% since April 6, 2016 and is uptrending. It has outperformed by 0.28% the S&P500.
The move comes after 9 months negative chart setup for the $34.09M company. It was reported on Nov, 8 by Barchart.com. We have $1.93 PT which if reached, will make NASDAQ:CYRX worth $3.75M less.
Analysts await CryoPort Inc (NASDAQ:CYRX) to report earnings on November, 21. They expect $-0.18 EPS, up 56.10% or $0.23 from last year’s $-0.41 per share. After $-0.19 actual EPS reported by CryoPort Inc for the previous quarter, Wall Street now forecasts -5.26% EPS growth.
According to Zacks Investment Research, “CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150Â° Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company’s products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.”
More notable recent CryoPort Inc (NASDAQ:CYRX) news were published by: Prnewswire.com which released: “Cryoport Expands Agreement with Stemedica to Support a Phase II Clinical Trial …” on August 11, 2016, also Prnewswire.com with their article: “Cryoport and Database Integrations Launch Integrated Solution to Manage …” published on September 22, 2016, Quotes.Wsj.com published: “CryoPort Inc. CYRX (US: Nasdaq)” on February 15, 2011. More interesting news about CryoPort Inc (NASDAQ:CYRX) were released by: Prnewswire.com and their article: “ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products” published on July 14, 2015 as well as Streetinsider.com‘s news article titled: “Cryoport, Inc. (CYRX) Prices 2M Public Offering at $3.25/Unit” with publication date: July 24, 2015.
CYRX Company Profile
Cryoport, Inc. (Cryoport), incorporated on May 25, 1990, is a well-known provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Firm provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company’s clients include companies and institutions that require cryogenic logistics solutions, such as therapy developers for personalized medicine, bio-pharmaceuticals, research, contract research organizations, diagnostic laboratories, contract manufacturers, cord blood repositories, vaccine manufacturers, animal husbandry related companies and in-vitro fertilization clinics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.